Company Overview and News
Following on from news earlier this week that the deal between Golding Contractors and Wonbindi Coal over the Baralaba North coal mine had increased in value from $350 million to $420 million thanks to a three-day extension on the limited notice to proceed (LNTP), the two companies have announced that terms have been finalised. Golding and Wonbindi are subsidiaries of NRW Holdings and Baralaba Coal, respectively.
Two Perth-based contractors have secured new work, with Decmil Group locking in a $NZ24.3 million ($22.7 million) contract for two school projects in New Zealand, while NRW Holdings will complete work for Rio Tinto.
Rio Tinto has awarded NRW Holdings an early contract involvement (ECI) contract to provide project development services.
NRW Holdings subsidiary, Golding Contractors, and Wonbindi Coal have extended a limited notice to proceed (LNTP) in regards to the mine plan and contract at the Baralaba North metallurgical coal mine in Queensland.
Gascoyne Resources is two months away from producing first gold at the Dalgaranga gold project in Western Australia.
A number of Western Australian mining companies have moved up the stock market rankings, with contractor Ausdrill included in the S&P ASX 200 index, while South32 has been admitted into the top 20 as part of the market’s quarterly rebalance.
NRW Holdings has announced that subsidiary Golding Contractors has executed a limited notice to proceed (LNTP) with Wonbindi Coal and Baralaba Coal Company on the Baralaba North coal project in Queensland.
NRW Holdings has been awarded a major earthworks and civil works contract worth $37 million at Rio Tinto’s Marandoo iron mine in the Pilbara, Western Australia.
Two local contractors have secured more than $70 million of work, with NRW Holdings locking in a $37 million contract at Rio Tinto’s Marandoo mine in the Pilbara.
Mining contractor NRW Holdings has recorded strong growth in underlying earnings for the half-year, but has decided against paying a dividend to ensure debt is fully serviced.
Gold developer Gascoyne Resources has released an update on its Dalgaranga gold project in the Murchison region of Western Australia, saying it is ahead of schedule by a month.
Gold developer Gascoyne Resources has confirmed that NRW Holdings will be its mining contractor at the Dalgaranga operation in the Murchison region of Western Australia.
Gascoyne Resources has secured an agreement with Commonwealth Bank of Australia (CBA) and National Australia Bank (NAB) for $60 million in funding for its Dalgaranga gold project in Western Australia.
Gold developer Gascoyne Resource remains on track to be producing at its Dalgaranga operation in Western Australia during the second quarter of 2018.
Indigenous contracting group Eastern Guruma, which has contracts or joint ventures with the likes of Rio Tinto, Fortescue Metals Group, NRW Holdings and Carnegie Clean Energy, has been placed into administration.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...